These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anemia of renal failure. Use of erythropoietin. Humphries JE Med Clin North Am; 1992 May; 76(3):711-25. PubMed ID: 1578966 [TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human erythropoietin (rHuEPO) on nutritional status of hemodialysis patients: investigation of direct anabolic effects of rHuEPO. Usuba T; Kuno T; Higuchi T; Kikuchi F; Nagura Y; Kanmatsuse K; Takahashi S Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1288-95. PubMed ID: 7853762 [TBL] [Abstract][Full Text] [Related]
6. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group. Nissenson AR Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075 [TBL] [Abstract][Full Text] [Related]
7. The beneficial effect of low initial dose and gradual increase of erythropoietin treatment in hemodialysis patients. Walter J; Gål J; Taraba I Artif Organs; 1995 Jan; 19(1):76-80. PubMed ID: 7741644 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin therapy in children on dialysis. Jabs K; Harmon WE Adv Ren Replace Ther; 1996 Jan; 3(1):24-36. PubMed ID: 8620365 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis. Shrivastava D; Rao TK; Sinert R; Khurana E; Lundin AP; Friedman EA Am J Kidney Dis; 1995 Jun; 25(6):904-9. PubMed ID: 7771487 [TBL] [Abstract][Full Text] [Related]
10. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Gaughan WJ; Liss KA; Dunn SR; Mangold AM; Buhsmer JP; Michael B; Burke JF Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363 [TBL] [Abstract][Full Text] [Related]
11. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis. Acharya VN; Sinha DK; Almeida AF; Pathare AV J Assoc Physicians India; 1995 Aug; 43(8):539-42. PubMed ID: 8772973 [TBL] [Abstract][Full Text] [Related]
12. Effect of hemodialysis and recombinant human erythropoietin on determinants of blood viscosity. Shand BI; Buttimore AL; Lynn KL; Bailey RR; Robson RA Ren Fail; 1994; 16(3):407-13. PubMed ID: 8059023 [TBL] [Abstract][Full Text] [Related]
13. Effect of purified recombinant human erythropoietin on anemia in rats with experimental renal failure induced by five-sixth nephrectomy. Kawamura A; Higuchi M; Imai N; Kawaguchi T; Ogura Y Biotherapy; 1990; 2(1):77-85. PubMed ID: 2400629 [TBL] [Abstract][Full Text] [Related]
14. Resistance to recombinant human erythropoietin in hemodialysis patients. Drüeke TB Am J Nephrol; 1990; 10 Suppl 2():34-9. PubMed ID: 2260616 [TBL] [Abstract][Full Text] [Related]
15. [Correction of anemia in chronic kidney failure with lyophilized recombinant human erythropoietin using a subcutaneous approach]. Amar M; Cendoroglo Neto M; Canziani ME; Nadaletto MA; Ajzen H; Draibe SA Rev Assoc Med Bras (1992); 1994; 40(2):101-7. PubMed ID: 7820145 [TBL] [Abstract][Full Text] [Related]
16. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Tarng DC; Huang TP; Chen TW; Yang WC Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294 [TBL] [Abstract][Full Text] [Related]
17. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency. Raja R; Bloom E; Johnson R; Goldstein M Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811 [TBL] [Abstract][Full Text] [Related]
18. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO). Campos A; Garin EH Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282 [TBL] [Abstract][Full Text] [Related]